Sorafenib-Associated Facial Acneiform Eruption
Author:
Publisher
Springer Science and Business Media LLC
Subject
Dermatology
Link
http://link.springer.com/content/pdf/10.1007/s13555-014-0067-9
Reference56 articles.
1. Scandurra G, Aiello RA, Ali M, Taibi E, Sano MV, Todaro FM, La Rocca R, Licciardello P, Caruso M. Appropriate management of cutaneous adverse events maximizes compliance with sorafenib treatment: a single center experience. Future Oncol. 2012;8:609–15 (PMID = 22646774).
2. Lee WJ, Lee JL, Chang SE, Lee MW, Kang YK, Choi JH, Moon KC, Koh JK. Cutaneous adverse effects in patients treated with the multitargeted kinase inhibitors sorafenib and sunitinib. Br J Dermatol. 2009;161:1045–51 (PMID = 19558553).
3. Vincenzi B, Santini D, Russo A, Addeo R, Guiliani F, Montella L, Rizzo S, Venditti O, Frezza AM, Caraglia M, Colucci G, Del Prete S, Tonini G. Early skin toxicity as a predictive factor for tumor control in hepatocellular carcinoma patients treated with sorafenib. Oncologist. 2010;15:85–92 (PMID = 20051477).
4. Ratain MJ, Eisen T, Stadler WM, Flaherty KT, Kaye SB, Rosner GL, et al. Phase II placebo-controlled randomized discontinuation trial of sorafenib in patients with metastatic renal cell carcinoma. J Clin Oncol. 2006;24:2505–12 (PMID = 16636341).
5. Wozel G, Sticherling M, Schon MP: Cutaneous side effects of inhibition of VEGF signal transduction. J DutschDermatolGes 2010;8:243-9 (PMID = 19832927).
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Acne and Environmental Factors;Acne;2021
2. Ulcerative skin lesion of the thigh caused by lenvatinib subscribed for hepatocellular carcinoma;Kanzo;2020-04-01
3. Facial nodulocystic eruption induced by sorafenib in a patient with hepatocellular carcinoma;Indian Journal of Dermatology, Venereology and Leprology;2020
4. Occupational and Environmental Acne;Kanerva’s Occupational Dermatology;2019-11-06
5. Éruption nodulo-kystique induite par le sorafénib;Annales de Dermatologie et de Vénéréologie;2019-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3